Simmaron Research is the second recipient of Solve’s ME/CFS Catalyst Award in support of its study,” “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” Read a preprint from Phase 1 of the trial here. The study advances an already FDA-approved drug for reducing key symptoms of ME/CFS and Long Covid, repurposing rapamycin […]
Chronic illnesses such as myalgic encephalomyelitis (ME) and Long COVID, which lack clinical biomarkers, present challenges around diagnosis, symptom reporting, and monitoring. That’s why the unhide® Solve Together Unified Platform–which is participant-led with continuous digital data collection–offers some advantages over traditional site-based clinical research models. The easy-to-use, secure platform allows patients to contribute data through […]
For the first time, scientists have developed a simple, accurate blood test that can potentially identify Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) — a long-term, debilitating condition that affects millions of patients worldwide. The study (published in the Journal of Translational Medicine), led by the University of East Anglia in partnership with Oxford BioDynamics, […]
Caring for someone with ME/CFS is an act of deep love–and preparation is one of the most meaningful ways to protect their future. Hosted by Solve M.E. Director of Advocacy Monique Wike, Andrew Kantor, Esq. (Senior Partner at Kantor & Kantor, LLP), will walk caregivers through essential legal and insurance strategies to support a loved […]
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar in people with Type 2 diabetes and promote substantial weight loss for individuals with a high body mass index (BMI) by slowing digestion, reducing appetite, […]
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst Award for their study searching for the exact proteins recognized by T-cell receptors from a person with ME/CFS and a person with Long Covid. These disease-associated T cells include “exhausted” CD8+ T cells and “double-positive” CD4+/CD8+ T cells (which are […]
The DecodeME Project is the largest genetic study of ME/CFS conducted to date and has identified eight genetic signals where people with ME/CFS tend to differ from those without, linked to the immune and nervous systems. These landmark findings reflect the lived experience of thousands of people with ME/CFS, providing validation and exciting new avenues for […]
In 2025, Simmaron Research was the second recipient of Solve’s ME/CFS Catalyst Award in support of its study, “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” The […]
Solve M.E. is proud to join our hosts from the Bateman Horne Center for a special edition of their program "Coffee with a Clinician" in observance of Severe ME/CFS Awareness Month. Solve President and CEO Emily Taylor, along with representatives from Open Medicine Foundation, #MEAction, and the authors of What is Myalgic Encephalomyelitis Like? will […]
As part of our commitment to advancing science that brings real hope to people living with ME/CFS or Long Covid, Solve has selected Dr. Jay H. Chung (National Institutes of […]
